Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvia Bellucci

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Bulletin De L'Academie Nationale De Medecine|December 13, 2007
[Vascular complications of essential thrombocythemia]Sylvia Bellucci
Bulletin De L'Academie Nationale De Medecine|June 13, 2014
[Blood platelets]Jacques Caen, Sylvia Bellucci
Seminars in Thrombosis and Hemostasis|July 1, 2006
The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemiaSylvia Bellucci, Jan J Michiels
British Journal of Haematology|October 3, 2012
Molecular determinants of platelet delta storage pool deficiencies: an updateJulien Masliah-Planchon, Luc Darnige, Sylvia Bellucci
Thrombosis Research|August 19, 2015
Low incidence of CALR gene mutations in patients with cerebral venous thrombosis without overt chronic myeloproliferative neoplasmEmmanuelle Verger, Isabelle Crassard, Bruno Cassinat, et al.
Thrombosis and Haemostasis|June 4, 2008
The V617F JAK 2 mutation is not a frequent event in patients with cerebral venous thrombosis without overt chronic myeloproliferative disorderSylvia Bellucci, Bruno Cassinat, Nadine Bonnin, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 18, 2004
Efficacy and safety of continuous infusion of factor VII concentrate in a factor VII-deficient patient at high risk for arterial thrombosisElisabeth Mazoyer, Jean-Philippe Kevorkian, Elisabeth Biyick, et al.
Clinical Imaging|January 18, 2011
Multiple intra-abdominal venous thrombosis in ulcerative colitis: role of MDCT for detectionArnaud Lefèvre, Philippe Soyer, Kouroche Vahedi, et al.
European Journal of Haematology|June 19, 2007
The V617F JAK2 mutation and the increase in platelet CD36 in essential thrombocythemia are unrelated eventsDhouha Darghouth, Bruno Cassinat, Bernadette Boval, et al.
Blood|May 28, 2011
The JAK2 46/1 haplotype in splanchnic vein thrombosisEirini Kouroupi, Jean-Jacques Kiladjian, Christine Chomienne, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Bulletin De L'Academie Nationale De Medecine|December 13, 2007
[Vascular complications of essential thrombocythemia]Sylvia Bellucci
Bulletin De L'Academie Nationale De Medecine|June 13, 2014
[Blood platelets]Jacques Caen, Sylvia Bellucci
Seminars in Thrombosis and Hemostasis|July 1, 2006
The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemiaSylvia Bellucci, Jan J Michiels
British Journal of Haematology|October 3, 2012
Molecular determinants of platelet delta storage pool deficiencies: an updateJulien Masliah-Planchon, Luc Darnige, Sylvia Bellucci
Thrombosis Research|August 19, 2015
Low incidence of CALR gene mutations in patients with cerebral venous thrombosis without overt chronic myeloproliferative neoplasmEmmanuelle Verger, Isabelle Crassard, Bruno Cassinat, et al.
Thrombosis and Haemostasis|June 4, 2008
The V617F JAK 2 mutation is not a frequent event in patients with cerebral venous thrombosis without overt chronic myeloproliferative disorderSylvia Bellucci, Bruno Cassinat, Nadine Bonnin, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 18, 2004
Efficacy and safety of continuous infusion of factor VII concentrate in a factor VII-deficient patient at high risk for arterial thrombosisElisabeth Mazoyer, Jean-Philippe Kevorkian, Elisabeth Biyick, et al.
Clinical Imaging|January 18, 2011
Multiple intra-abdominal venous thrombosis in ulcerative colitis: role of MDCT for detectionArnaud Lefèvre, Philippe Soyer, Kouroche Vahedi, et al.
European Journal of Haematology|June 19, 2007
The V617F JAK2 mutation and the increase in platelet CD36 in essential thrombocythemia are unrelated eventsDhouha Darghouth, Bruno Cassinat, Bernadette Boval, et al.
Blood|May 28, 2011
The JAK2 46/1 haplotype in splanchnic vein thrombosisEirini Kouroupi, Jean-Jacques Kiladjian, Christine Chomienne, et al.
Pageof 2